RT Journal Article
SR Electronic
T1 Explainable Brain Disease Classification and Relevance-Guided Deep Learning
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.09.21263013
DO 10.1101/2021.09.09.21263013
A1 Tinauer, Christian
A1 Heber, Stefan
A1 Pirpamer, Lukas
A1 Damulina, Anna
A1 Schmidt, Reinhold
A1 Stollberger, Rudolf
A1 Ropele, Stefan
A1 Langkammer, Christian
YR 2021
UL http://medrxiv.org/content/early/2021/09/13/2021.09.09.21263013.abstract
AB Deep neural networks are increasingly used for neurological disease classification by MRI, but the networks’ decisions are not easily interpretable by humans. Heat mapping by deep Taylor decomposition revealed that (potentially misleading) image features even outside of the brain tissue are crucial for the classifier’s decision. We propose a regularization technique to train convolutional neural network (CNN) classifiers utilizing relevance-guided heat maps calculated online during training. The method was applied using T1-weighted MR images from 128 subjects with Alzheimer’s disease (mean age=71.9±8.5 years) and 290 control subjects (mean age=71.3±6.4 years). The developed relevance-guided framework achieves higher classification accuracies than conventional CNNs but more importantly, it relies on less but more relevant and physiological plausible voxels within brain tissue. Additionally, preprocessing effects from skull stripping and registration are mitigated, rendering this practically useful in deep learning neuroimaging studies. Understanding the decision mechanisms underlying CNNs, these results challenge the notion that unprocessed T1-weighted brain MR images in standard CNNs yield higher classification accuracy in Alzheimer’s disease than solely atrophy.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02752750Funding StatementThis study was funded by the Austrian Science Fund (FWF grant numbers: KLI523, P30134). This research was supported by NVIDIA GPU hardware grants.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the ethics committee of the Medical University of Graz and signed written informed consent was obtained from all study participants or their caregivers. The trial protocol for this prospective study was registered at the National Library of Medicine (trial identification number: NCT02752750). Ethis comitee of Medical University of Graz, IRB00002556, https://www.medunigraz.at/en/ethics-committee Chair: Josef Haas Auenbruggerplatz 2, First Floor, 8036 Graz, ethikkommission{at}medunigraz.atAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSource code for Graz+ and the image preprocessing is available under www.neuroimaging.at/explainable-ai. The MR images used in this paper are part of a clinical data set and therefore are not publicly available. Formal data sharing requests will be considered.